Phase II Study of Toripalimab in Combination with Induction Chemotherapy and Subsequent Chemo-Radiation in Patients with Advanced/Metastatic Esophageal Carcinoma (TR-EAT Trial)
机构：[1]Department of Radiation Oncology, Sichuan Cancer Hospitale Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation oncology Key Laboratory of Sichuan Prov- ince, Chengdu, China,四川省人民医院四川省肿瘤医院[2]Sichuan Cancer Hospital Institute, Sichuan Can- cer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China,四川省人民医院四川省肿瘤医院[3]Sichuan Cancer hospital institute/ Sichuan Cancer Center/School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院[4]Sichuan Cancer hospital insti- tute/Sichuan Cancer Center/School of Medicine, University of Electronic Sci- ence and Technology of China, Chengdu, China, Chengdu, China,四川省肿瘤医院[5]Department of Radiation Oncology, Sichuan Cancer Hospital' Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院[6]Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, China四川省人民医院四川省肿瘤医院
出处：
ISSN：
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2022]版：
大类|1 区医学
小类|2 区核医学2 区肿瘤学
最新[2023]版：
大类|1 区医学
小类|2 区肿瘤学2 区核医学
JCR分区：
出版当年[2022]版：
Q1ONCOLOGYQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2023]版：
Q1ONCOLOGYQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
第一作者机构：[1]Department of Radiation Oncology, Sichuan Cancer Hospitale Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation oncology Key Laboratory of Sichuan Prov- ince, Chengdu, China,
推荐引用方式(GB/T 7714)：
Wu L.,Li B.,Wan G.,et al.Phase II Study of Toripalimab in Combination with Induction Chemotherapy and Subsequent Chemo-Radiation in Patients with Advanced/Metastatic Esophageal Carcinoma (TR-EAT Trial)[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2022,114(3):E167-E168.
APA：
Wu, L.,Li, B.,Wan, G.,Liang, L.,Li, T....&Wang, Q..(2022).Phase II Study of Toripalimab in Combination with Induction Chemotherapy and Subsequent Chemo-Radiation in Patients with Advanced/Metastatic Esophageal Carcinoma (TR-EAT Trial).INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,114,(3)
MLA：
Wu, L.,et al."Phase II Study of Toripalimab in Combination with Induction Chemotherapy and Subsequent Chemo-Radiation in Patients with Advanced/Metastatic Esophageal Carcinoma (TR-EAT Trial)".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 114..3(2022):E167-E168
医学